Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer
about
Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.Aberrant gene promoter methylation associated with sporadic multiple colorectal cancerPediatric low-grade gliomas: how modern biology reshapes the clinical field.Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumourThe yin and yang of kidney development and Wilms' tumorsDNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polypsMethylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.Quantitative analysis of cancer-associated gene methylation connected to risk factors in Korean colorectal cancer patientsGametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies.Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinomaDetection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.Toward a comprehensive and systematic methylome signature in colorectal cancers.Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK.Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal CancerColorectal cancer and RASSF family--a special emphasis on RASSF1A.The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis.The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis.Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop.Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas.Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studiesGenetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of in Wilms tumour susceptibilityDiagnostic potential of methylated in brushing samples of nasopharyngeal carcinoma
P2860
Q30945124-BDD358FE-CA03-4303-9DCA-265B85B7E67BQ33526369-5DC56D30-94C6-463F-A736-EA261E0F7DABQ33847771-897425E2-9874-461F-86E4-63E01B488605Q35027111-3EBDE717-381C-4F27-9A59-83994D3AA6A8Q35163343-3126998B-AC83-4CE2-9919-B669CE73F035Q35173260-DA35787A-382D-4932-86E4-019263201276Q35785652-4CD49EF8-6CEC-4702-B232-033BCDAF00C3Q36076356-7352CEA1-09BE-46E5-9DA8-48E79594001BQ36144242-D753B904-E309-49A8-9E90-1CAF1EC0177AQ36251483-059D3551-D486-4C78-B258-686FB8473A02Q36517724-3CD09B16-6FB7-45B8-A707-13CE223CCE5FQ36610632-594208AA-8360-4BCF-BE05-E3AAE75ED8F5Q36694377-DE50F496-BFE7-4420-8BD0-0F7AF9F54438Q37265620-9B109B26-D954-4119-B1F6-A0AF1DE01297Q37445275-81196A64-96EF-4B28-AA17-FE461714D7A4Q37536803-3A6E85FF-BDC3-4C80-9420-272B81FE6AB5Q37539515-4273D91D-0957-4189-BFF6-B6A2C49E3113Q38021701-B1949057-43E2-4269-BB94-90B438B96C22Q38764772-C695ACC4-4BE9-4C3E-AA7B-EA62DCD284D1Q38893314-0735C1A4-C259-455C-A132-D9581181B0AAQ40379135-A5981080-CAED-4F75-B4AA-D47F0ADE5CFAQ42277975-7E64C230-1E65-4066-B4B4-3AC34D8B36D3Q42719109-AC06DFD2-4C65-447A-A151-61F56E7BF9FEQ42995400-058C0D31-11F3-44FF-B52A-1366587A7228Q47445963-61EACFA5-3295-4CE6-A504-C4C2BB756703Q54434319-CB9F9F7B-7EEF-4F3C-84FE-9734BA8A6E4AQ56519160-89D002FC-15C1-400A-AB2C-C313AB669851Q57821557-296A9FFA-0BA3-4EA4-80CF-A07EF4CD89E4Q58698636-EED6DBFA-5FC8-4FFC-A93F-2C31C93699B2
P2860
Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer
description
article
@en
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2002
@uk
name
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@en
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@nl
type
label
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@en
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@nl
prefLabel
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@en
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@nl
P2093
P2860
P356
P1433
P1476
Frequent RASSF1A tumour suppre ...... ' tumour and colorectal cancer
@en
P2093
Carolyn Jones
Dion Morton
Farida Latif
Germaine Caldwell
Kate J Wagner
Paul N Schofield
Richard G Grundy
Roy B Wadey
Wendy N Cooper
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205922
P407
P577
2002-10-01T00:00:00Z